The role of dopamine in the mouse frontal cortex: A new hypothesis of behavioral sensitization to amphetamine and cocaine

Pharmacology Biochemistry and Behavior

Volumn 61, Issue 4, 1998, Pages 435-443

  Karler, Ralph ^a   Calder, Larry D ^a   Thai, David K ^a   Bedingfield, J Brent ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Cocaine; Cortex; Dopamine; GABA; Motor effects; Mouse; Sensitization

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; BICUCULLINE; COCAINE; ETICLOPRIDE; GABOXADOL;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FRONTAL CORTEX; GABAERGIC SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; STEREOTYPY;

AMPHETAMINE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FRONTAL LOBE; MALE; MICE; STEREOTYPIC MOVEMENT DISORDER;

EID: 0031792785     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00133-6     Document Type: Article

References (49)

1. Bedingfield, J. B.; Calder, L. D.; Karler, R.: Comparative behavioral sensitization to stereotypy by direct and indirect dopamine agonists in CF-1 mice. Psychopharmacology (Berlin) 124:219-225; 1996.
2. Bedingfield, J. B.; Calder, L. D.; Thai, D. K.; Karler, R.: The role of the striatum in the mouse in behavioral sensitization to amphetamine. Pharmacol. Biochem. Behav. 56:305-310; 1997.
3. Bickerdike, M. J.; Abercrombie, E. D.: Striatal acetylcholine release correlates with behavioral sensitization in rats withdrawn from chronic amphetamine. J. Pharmacol. Exp. Ther. 282:818-826; 1997.
4. Cowan, R. L.; Sesack, S. R.; Van Bockstaele, J.; Branchereau, P.; Chan, J.; Pickel, V. M.: Analysis of synaptic inputs and targets of physiologically characterized neurons in rat frontal cortex: Combined in vivo intracellular recording and immunolabeling. Synapse 17:101-114; 1994.
5. Curran, E. J.; Akil, H.; Watson, S. J.: Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: Comparisons between acute drug treatment and a drug challenge in sensitized animals. Neurochem. Res. 21:1425-1435; 1996.
6. Deutch, A. Y.: The regulation of subcortical dopamine systems by the prefrontal cortex: Interactions of central dopamine systems and the pathogenesis of schizophrenia. J. Neural Transm. 36:61-89; 1992.
7. Duvauchelle, C. L.; Levitin, M.; MacConell, L. A.; Lee, L. K.; Ettenberg, A.: Opposite effects of prefrontal cortex and nucleus accumbens infusions of flupenthixol on stimulant-induced locomotion and brain stimulation reward. Brain Res. 576:104-110; 1992.
8. Ferron, A.; Thierry, A.-M.; Le Douarin, C.; Glowinski, J.: Inhibitory influence of the mesocortical dopaminergic system on spontaneous activity or excitatory response induced from the thalamic mediodorsal nucleus in the rat medial prefrontal cortex. Brain Res. 302:257-265; 1984.
9. Franklin, B. J.; Paxinos, G.: The mouse brain in stereotaxic coordinates. New York:Academic Press; 1997.
10. Gellman, R. L.; Aghajanian, G. K.: Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons. Brain Res. 600:63-73; 1993.
11. Godbout, R.; Mantz, J.; Pirot, S.; Glowinski, J.; Thierry, A.-M.: Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: Electrophysiological and pharmacological characterization. J. Pharmacol. Exp. Ther. 258:728-738; 1991.
12. Goldman-Rakic, P. S.; Leranth, C.; Williams, S. M.; Mons, N.; Geffard, M.: Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc. Natl. Acad. Sci. USA 86:9015-9019; 1989.
13. Heidbreder, C.; Shoaib, M.; Shippenberg, T. S.: Differential role of δ-opioid receptors in the development and expression of behavioral sensitization to cocaine. Eur. J. Pharmacol. 298:207-216; 1996.
14. Heidbreder, C. A.; Thompson, A. C.; Shippenberg, T. S.: Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 278:490-502; 1996.
15. Hitzeman, R.; Curell, J.: Effects of naloxone on d-amphetamine-and apomorphine-induced behavior. Neuropharmacology 24:1005-1011; 1982.
16. Hurd, Y. L.; Weiss, F.; Koob, G.: The influence of cocaine self-administration on in vivo dopamine and acetylcholine neurotransmission in rat caudate-putamen. Neurosci. Lett. 109:227-233; 1990.
17. Jones, D. N. C.; Bowen, W. D.; Portoghese, P. S.; Holtzman, S. G.: δ8-Opioid receptor antagonists attenuate motor activity induced by amphetamine but not cocaine. Eur. J. Pharmacol. 249:167-177; 1993.
18. Jones, D. N. C.; Holtzman, S. G.: Interaction between opioid antagonists and amphetamine: Evidence for mediation by central delta opioid receptors. J. Pharmacol. Exp. Ther. 262:638-645; 1992.
19. Karler, R.; Bedingfield, J. B.; Thai, D. K.; Calder, L. D.: The role of the frontal cortex in the mouse in behavioral sensitization to amphetamine. Brain Res. 757:228-235; 1997.
20. Karler, R.; Calder, L. D.; Bedingfield, J. B.: A novel nicotiniccholinergic role in behavioral sensitization to amphetamine-induced stereotypy in mice. Brain Res. 725:192-198; 1996.
21. Karler, R.; Calder, L. D.; Thai, D. K.; Bedingfield, J. B.: The role of dopamine and GABA in the frontal cortex of mice in modulating the motor-stimulant effect of amphetamine and cocaine. Pharmacol. Biochem. Behav. 60:237-244; 1998.
22. Karler, R.; Calder, L. D.; Thai, L. H.; Bedingfield, J. B.: A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine. Brain Res. 658:8-14; 1994.
23. Karler, R.; Calder, L. D.; Thai, L. H.; Bedingfield, J. B.: The dopaminergic, glutamatergic, GABAergic basis for the action of amphetamine and cocaine. Brain Res. 671:100-104; 1995.
24. Karler, R.; Calder, L. D.; Turkanis, S. A.: Calcium channel block-ers and excitatory amino acids. Brain Res. 551:331-333; 1991.
25. Karler, R.; Calder, L. D.; Turkanis, S. A.: DNQX blockade of amphetamine behavioral sensitization. Brain Res. 552:295-300; 1991.
26. Karler, R.; Chaudhry, I. A.; Calder, L. D.; Turkanis, S. A.: Amphetamine behavioral sensitization and the excitatory amino acids. Brain Res. 537:76-82; 1990.
27. Karler, R.; Finnegan, K. T.; Calder, L. D.: Blockade of behavioral sensitization to cocaine and amphetamine by inhibitors of protein synthesis. Brain Res. 603:19-24; 1993.
28. Karler, R.; Turkanis, S. A.; Calder, L. D.: Excitatory amino acids and the actions of cocaine. Brain Res. 582:143-146; 1992.
29. Litchfield, J. T., Jr.; Wilcoxon, F.: A simplified method for evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:99-113; 1949.
30. Louilot, A.; LeMoal, M.; Simon, H.: Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens. An in vivo voltammetric study. Neuroscience 29:45-56; 1989.
31. Murase, S.; Grenhoff, J.; Chouvet, G.; Gonon, F. G.; Svensson, T. H.: Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci. Lett. 157:53-56; 1993.
32. 2 dopamine receptor agonists in the medial prefrontal cortex of young and aged Fischer 344 rats. J. Pharmacol. Exp. Ther. 254:539-545; 1990.
33. Penit-Soria, J.; Audinat, E.; Crepel, F.: Excitation of rat prefrontal cortical neurons by dopamine: An in vitro electrophysiological study. Brain Res. 425:363-374; 1987.
34. Pierce, R. C.; Kalivas, P. W.: A circuity model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25:192-216; 1997.
35. Pirot, S.; Godbout, R.; Mantz, J.; Tassin, J.-P.; Glowinski, J.; Thierry, A.-M.: Inhibitory effects of ventral tegmental area stimulation on the activity of prefrontal cortical neurons: Evidence for the involvement of both dopaminergic and gabaergic components. Neuroscience 49:857-865; 1992.
36. Rebec, G. V.; Segal, D. S.: Apparent tolerance to some aspects of amphetamine stereotypy with long-term treatment. Pharmacol. Biochem. Behav. 13:793-797; 1980.
37. Segal, D. S.; Kuczenski, R.: Behavioral and neurochemical characteristics of stimulant-induced augmentation. Psychopharmacol. Bull. 23:417-424; 1987.
38. Segal, D. S.; Kuczenski, R.: Behavioral pharmacology of amphetamine. In: Cho, A. K.; Segal, D. S., eds. Amphetamine and its analogues: Psychopharmacology, toxicology and abuse. San Diego: Academic Press, Inc.; 1994:115-150.
39. Segal, D. S.; Weinberger, S.; Cahill, J.; McCunney, S.: Multiple daily amphetamine administration: Behavioral and neurochemical alterations. Science 207:904-907; 1980.
40. Seguela, P.; Watkins, K. C.; Descarries, L.: Ultrastructural features of dopamine axon terminals in the anteromedial and the suprahinal cortex of adult rat. Brain Res. 442:11-22; 1988.
41. 2 mediated? Ann. NY Acad. Sci. 537:529-530; 1988.
42. Sesack, S. R.; Bunney, B. S.: Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: A microiontophoretic study. J. Pharmacol. Exp. Ther. 248:1323-1333; 1989.
43. Sesack, S. R.; Snyder, C. L.; Lewis, D. A.: Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J. Comp. Neurol. 363:264-280; 1995.
44. Thierry, A. M.; Godbout, R.; Mantz, J.; Glowinski, J.: Influence of the ascending monoaminergic systems on the activity of the rat prefrontal cortex. In: Uylings, H. B. M.; Van Eden, C. G.; De Bruin, J. P. C.; Corner, M. A.; Feenstra, M. P. G., eds. The prefrontal cortex: Its structure, function, and pathology (progress in brain research 85). Amsterdam: Elsevier Science Publishers; 1990:366-377.
45. Thierry, A. M.; Le Douarin, C.; Penit, J.; Ferron, A.; Glowinski, J.: Variation in the ability of neuroleptics to block the inhibitory influence of dopaminergic neurons on the activity of cells in the rat prefrontal cortex. Brain Res. Bull. 16:155-160; 1986.
46. Thierry, A.-M.; Tassin, J.-P.; Glowinski, J.: Biochemical and electrophysiological studies of the mesocortical dopamine system. In: Descarries, L.; Reader, T. R.; Jasper, H. H., eds. Monamine innervation of cerebral cortex. New York: Alan R. Liss, Inc.; 1984:233-261.
47. Vezina, P.; Blanc, G.; Glowinski, J.; Tassin, J.-P.: Opposed behavioral outputs of increased dopamine transmission in prefronto-cortical and subcortical areas: A role for the cortical D-1 dopamine receptor. Eur. J. Neurosci. 3:1001-1007; 1991.
48. 1 receptors in the prefrontal cortex. Nature 376:572-575; 1995.
49. 1 receptor actions in layers V-VI in rat prefrontal cortex neurons in vitro: Modulation of dendritic-somatic signal integration. J. Neurosci. 16:1922-1935; 1996.